Stock Expert AI

Astrana Health, Inc. (ASTH)

Astrana Health, Inc. operates as a healthcare management company in the United States, focusing on value-based care. The company leverages its technology platform and integrated model to empower providers and improve patient outcomes.

53/100 AI Score MCap 1B Vol 579K

Company Overview

CEOBrandon K. Sim
Employees1900
HeadquartersAlhambra, CA, US
Founded2009

Astrana Health (ASTH) is a physician-centric, technology-powered healthcare management company driving value-based care through its integrated platform. With a focus on care coordination and a growing network, Astrana Health is positioned to capitalize on the shift towards preventative, patient-centered healthcare, despite its current low profit margin of 0.3%.

Investment Thesis

Astrana Health presents a compelling investment opportunity due to its focus on value-based care and technology-driven healthcare management. The company's integrated platform and physician-centric approach are well-aligned with the industry's shift towards preventative and coordinated care. While the current P/E ratio is high at 108.83 and the profit margin is low at 0.3%, the company's strategic positioning and growth opportunities could drive future profitability. Key catalysts include expanding its care network, leveraging its technology platform for greater efficiency, and capitalizing on the growing demand for value-based care models. The company's beta of 0.89 suggests lower volatility compared to the market, making it a potentially attractive option for risk-averse investors seeking exposure to the healthcare sector.

Key Highlights

  • Market capitalization of $1.06 billion, reflecting investor confidence in Astrana Health's growth potential.
  • Operates through three segments: Care Partners, Care Delivery, and Care Enablement, providing a comprehensive suite of healthcare services.
  • P/E ratio of 108.83, indicating a premium valuation based on current earnings.
  • Gross margin of 10.1%, highlighting opportunities for improvement in operational efficiency.
  • Beta of 0.89, suggesting lower volatility compared to the overall market.

Competitors

Acadia Healthcare CompanyAddus HomeCare CorporationHealthcare Services GroupLifeStance Health Group, Inc.Mednax Inc

Strengths

  • Proprietary technology platform for population health management.
  • Integrated value-based care model.
  • Established physician network.
  • Focus on care coordination services.

Weaknesses

  • Low profit margin of 0.3%.
  • High P/E ratio of 108.83.
  • Reliance on insurance reimbursements.
  • Limited geographic diversification.

Catalysts

  • Upcoming: Expansion of the care network to new geographic areas.
  • Ongoing: Continued development and integration of the technology platform.
  • Ongoing: Increasing adoption of value-based care models by payers and providers.
  • Upcoming: Potential strategic acquisitions to expand service offerings.
  • Ongoing: Positive results from clinical trials or research studies demonstrating the effectiveness of the company's care model.

Risks

  • Potential: Changes in healthcare regulations, such as the Affordable Care Act, could negatively impact the company's business.
  • Ongoing: Increased competition from other healthcare providers could erode market share and profitability.
  • Ongoing: Pressure from payers to reduce reimbursement rates could squeeze margins.
  • Potential: Economic downturn could reduce patient access to healthcare and negatively impact revenue.
  • Potential: Cybersecurity breaches or data privacy violations could damage the company's reputation and result in financial losses.

Growth Opportunities

  • Expanding Care Network: Astrana Health has the opportunity to expand its network of primary care physicians, specialist physicians, and extenders. By increasing its network coverage, the company can reach a larger patient population and drive revenue growth. The market for physician network expansion is significant, with the potential to capture a larger share of the healthcare market. Timeline: Ongoing.
  • Leveraging Technology Platform: Astrana Health's proprietary population health management and healthcare delivery platform offers significant growth opportunities. By further developing and integrating its technology, the company can improve care coordination, enhance patient engagement, and drive operational efficiencies. The market for healthcare technology solutions is rapidly growing, driven by the need for improved data analytics and patient management. Timeline: Ongoing.
  • Capitalizing on Value-Based Care: The shift towards value-based care models presents a major growth opportunity for Astrana Health. By demonstrating improved patient outcomes and cost savings, the company can attract more patients, physician groups, and health plans. The market for value-based care is expanding as healthcare providers and payers seek to improve quality and reduce costs. Timeline: Ongoing.
  • Strategic Acquisitions: Astrana Health can pursue strategic acquisitions to expand its geographic reach, enhance its service offerings, and gain access to new technologies. The market for healthcare acquisitions is active, with numerous opportunities to acquire complementary businesses. Timeline: Ongoing.
  • Expanding Service Offerings: Astrana Health can expand its service offerings to include additional healthcare services, such as telehealth, remote patient monitoring, and chronic disease management. By offering a broader range of services, the company can attract more patients and generate additional revenue streams. The market for these services is growing rapidly, driven by the increasing demand for convenient and accessible healthcare. Timeline: Ongoing.

Opportunities

  • Expanding care network.
  • Capitalizing on the shift towards value-based care.
  • Strategic acquisitions.
  • Expanding service offerings.

Threats

  • Changes in healthcare regulations.
  • Increased competition from other healthcare providers.
  • Pressure from payers to reduce reimbursement rates.
  • Economic downturn affecting patient access to healthcare.

Competitive Advantages

  • Proprietary Technology Platform: Astrana Health's population health management and healthcare delivery platform provides a competitive advantage by enabling efficient care coordination and data-driven decision-making.
  • Integrated Value-Based Care Model: The company's integrated model aligns incentives between providers and payers, leading to improved patient outcomes and cost savings.
  • Established Physician Network: Astrana Health's network of primary care physicians, specialists, and hospitalists provides a strong foundation for growth and expansion.
  • Care Coordination Services: Astrana Health's care coordination services differentiate it from competitors and enhance patient engagement.

About

Astrana Health, Inc., formerly known as Apollo Medical Holdings, Inc., was incorporated in 1985 and rebranded in February 2024, signaling a renewed focus on its mission. Headquartered in Alhambra, California, Astrana Health operates as a physician-centric, technology-powered healthcare management company. The company's core business revolves around providing medical care services within the United States. Astrana Health operates through three key segments: Care Partners, Care Delivery, and Care Enablement. These segments work synergistically to deliver a comprehensive suite of healthcare services. Astrana Health leverages its proprietary population health management and healthcare delivery platform to operate an integrated, value-based healthcare model. This model empowers providers within its network to deliver enhanced care to their patients. The company offers care coordination services, extending its reach to patients, families, primary care physicians, specialists, acute care hospitals, alternative inpatient care sites, physician groups, and health plans. Astrana Health's physician network comprises primary care physicians, specialist physicians and extenders, and hospitalists. The company serves a diverse patient base, primarily those covered by private or public insurance, including Medicare, Medicaid, and health maintenance organization plans, as well as non-insured patients. Astrana Health's commitment to technology and value-based care positions it as a key player in the evolving healthcare landscape.

What They Do

  • Provides medical care services in the United States.
  • Operates through three segments: Care Partners, Care Delivery, and Care Enablement.
  • Leverages a proprietary population health management and healthcare delivery platform.
  • Operates an integrated, value-based healthcare model.
  • Offers care coordination services to patients, families, and healthcare providers.
  • Manages a physician network consisting of primary care physicians, specialists, and hospitalists.
  • Serves patients covered by private or public insurance, as well as non-insured patients.

Business Model

  • Generates revenue through providing medical care services to patients.
  • Receives payments from private and public insurance plans, including Medicare and Medicaid.
  • Contracts with health maintenance organizations (HMOs) to provide care to their members.
  • Offers care coordination services to healthcare providers and organizations.

FAQ

What does Astrana Health, Inc. do?

Astrana Health, Inc. operates as a healthcare management company, providing medical care services in the United States. The company's core business revolves around its integrated, value-based healthcare model, which empowers providers to deliver enhanced care to their patients. Astrana Health leverages its proprietary population health management and healthcare delivery platform to offer care coordination services to patients, families, primary care physicians, specialists, acute care hospitals, and health plans. The company generates revenue through providing medical care services to patients and receiving payments from private and public insurance plans.

Is ASTH stock a good buy?

ASTH stock presents a mixed investment profile. The company's focus on value-based care and technology-driven healthcare management aligns with industry trends, offering potential for long-term growth. However, the high P/E ratio of 108.83 and low profit margin of 0.3% raise concerns about valuation and profitability. Investors should carefully consider the company's growth opportunities, competitive landscape, and potential risks before making an investment decision. Monitoring the company's progress in expanding its care network, improving operational efficiency, and capitalizing on value-based care initiatives is crucial.

What are the main risks for ASTH?

Astrana Health faces several key risks, including changes in healthcare regulations, increased competition, and pressure from payers to reduce reimbursement rates. Changes in regulations, such as modifications to the Affordable Care Act, could significantly impact the company's business model and revenue streams. Increased competition from other healthcare providers could erode market share and profitability. Additionally, pressure from payers to reduce reimbursement rates could squeeze margins and negatively impact financial performance. Economic downturns could also reduce patient access to healthcare, affecting revenue.

Industry Context

Astrana Health operates within the medical care facilities industry, a segment experiencing growth driven by an aging population and increasing demand for healthcare services. The industry is undergoing a shift towards value-based care models, emphasizing preventative care and improved patient outcomes. Astrana Health's focus on technology and integrated care positions it favorably within this evolving landscape. Competitors include companies like Acadia Healthcare Company (ACHC), which operates behavioral healthcare facilities, and Addus HomeCare Corporation (AVAH), which provides home care services. The industry is characterized by increasing consolidation and a focus on efficiency and cost containment.

Key Customers

  • Patients covered by private insurance plans.
  • Patients covered by public insurance plans, such as Medicare and Medicaid.
  • Health maintenance organizations (HMOs).
  • Primary care physicians, specialist physicians, and hospitalists.
AI Confidence: 73% Updated: 2/9/2026

Financials

Recent Quarterly Results

Quarter Revenue Net Income EPS
Q3 2025 $956M $373,000 $0.01
Q2 2025 $655M $9M $0.19
Q1 2025 $620M $7M $0.14
Q4 2024 $665M -$7M $-0.15

Source: Company filings

Chart & Info

Price Chart

Astrana Health, Inc. (ASTH) stock price: $27.40 (+2.18, +8.64%)

Why Bull

  • Recent insider buying suggests confidence in Astrana's strategic direction, indicating that key stakeholders believe in the company's future.
  • Community sentiment has shifted positively as discussions around innovative health solutions gain traction, reflecting a growing interest in Astrana's offerings.
  • Market perception has been bolstered by recent partnerships that enhance Astrana's credibility and expand its reach in the healthcare sector.
  • Positive media coverage highlighting Astrana's advancements in health technology has contributed to a more favorable view among investors.

Why Bear

  • Concerns around regulatory hurdles in the healthcare industry could impact Astrana's growth trajectory and market entry strategies.
  • Bearish sentiment has emerged due to uncertainties in the overall market environment, causing some investors to adopt a cautious approach.
  • Recent earnings reports have raised questions about the sustainability of Astrana's business model, leading to skepticism among some analysts.
  • Increased competition in the health tech space may dilute Astrana's market share, raising concerns about its ability to maintain a competitive edge.

Latest News

Technical Analysis

bearish Trend
RSI(14)
34.2
MACD
--
Volume
578,348

Rationale

AI-generated technical analysis for ASTH including trend direction, momentum, and pattern recognition.

What to Watch

Key support and resistance levels, volume signals, and upcoming events.

Risk Management

Position sizing, stop-loss levels, and risk-reward assessment.

Community

Discussion

Share your analysis and discuss Astrana Health, Inc. (ASTH) with other investors. Log in to post.

Sentiment

Community sentiment and discussion activity for ASTH.

Make a Prediction

Set your price target for Astrana Health, Inc. (ASTH), choose a timeframe, and track your prediction accuracy.

Current price: $27.40

Analyst Consensus

Consensus Rating

Aggregated Buy/Hold/Sell recommendations from Benzinga, Yahoo Finance, and Finnhub for ASTH.

Price Targets

Low
$26.00
Consensus
$32.75
High
$40.00

Median: $32.50 (+19.5% from current price)

Insider Flow (30d)

Sim Brandon
Insider
2 weeks ago
BOUGHT
0 shares
Sim Brandon
Insider
2 weeks ago
BOUGHT
1,045,329 shares
$24.3M
Schmidt David
Insider
1 month ago
BOUGHT
0 shares
Schmidt David
Insider
1 month ago
BOUGHT
35,763 shares
$207K
Lam Thomas S.
Insider
2 months ago
BOUGHT
0 shares
Lam Thomas S.
Insider
2 months ago
BOUGHT
459,122 shares
$8.2M

MoonshotScore

53/100

Score Factors

  • Revenue Growth 6/100
  • Gross Margin 3/100
  • Operating Leverage 6/100
  • Cash Runway 8/100
  • R&D Intensity 5/100
  • Insider Activity 6/100
  • Short Interest 10/100
  • Price Momentum 0/100
  • News Sentiment 5/100

What does this score mean?

The MoonshotScore rates ASTH's growth potential on a scale of 0-100 across multiple factors including innovation, market disruption, financial health, and momentum.

Classification

Sector Healthcare Industry Medical - Care Facilities

Competitors & Peers

Latest News

Frequently Asked Questions

What does Astrana Health, Inc. do?

Astrana Health, Inc. operates as a healthcare management company, providing medical care services in the United States. The company's core business revolves around its integrated, value-based healthcare model, which empowers providers to deliver enhanced care to their patients. Astrana Health leverages its proprietary population health management and healthcare delivery platform to offer care coordination services to patients, families, primary care physicians, specialists, acute care hospitals, and health plans. The company generates revenue through providing medical care services to patients and receiving payments from private and public insurance plans.

Is ASTH stock a good buy?

ASTH stock presents a mixed investment profile. The company's focus on value-based care and technology-driven healthcare management aligns with industry trends, offering potential for long-term growth. However, the high P/E ratio of 108.83 and low profit margin of 0.3% raise concerns about valuation and profitability. Investors should carefully consider the company's growth opportunities, competitive landscape, and potential risks before making an investment decision. Monitoring the company's progress in expanding its care network, improving operational efficiency, and capitalizing on value-based care initiatives is crucial.

What are the main risks for ASTH?

Astrana Health faces several key risks, including changes in healthcare regulations, increased competition, and pressure from payers to reduce reimbursement rates. Changes in regulations, such as modifications to the Affordable Care Act, could significantly impact the company's business model and revenue streams. Increased competition from other healthcare providers could erode market share and profitability. Additionally, pressure from payers to reduce reimbursement rates could squeeze margins and negatively impact financial performance. Economic downturns could also reduce patient access to healthcare, affecting revenue.

Disclaimer: This content is for informational purposes only and does not constitute investment advice. Always do your own research and consult a financial advisor.

Data provided for informational purposes only.